794
Views
17
CrossRef citations to date
0
Altmetric
Original Article

An elevated fetal interleukin-6 concentration can be observed in fetuses with anemia due to Rh alloimmunization: implications for the understanding of the fetal inflammatory response syndrome

, , , , , & show all
Pages 391-396 | Received 21 Jun 2010, Accepted 06 Jul 2010, Published online: 11 Aug 2010

Figures & data

Table I.  Demographic and clinical characteristics of the study population.

Figure 1.  Correlation between fetal hematocrit and plasma IL-6 concentration among 16 fetuses with Rh alloimmunization who underwent cordocentesis for suspected anemia. There was a significant negative correlation between the fetal hematocrit and plasma IL-6 concentration (Spearman's rho −0.68, p = 0.004). The interrupted line represents the cutoff value of IL-6 concentration for the diagnosis of FIRS. Four fetuses (‘empty’ dots) were diagnosed with FIRS.

Figure 1.  Correlation between fetal hematocrit and plasma IL-6 concentration among 16 fetuses with Rh alloimmunization who underwent cordocentesis for suspected anemia. There was a significant negative correlation between the fetal hematocrit and plasma IL-6 concentration (Spearman's rho −0.68, p = 0.004). The interrupted line represents the cutoff value of IL-6 concentration for the diagnosis of FIRS. Four fetuses (‘empty’ dots) were diagnosed with FIRS.

Figure 2.  Comparison of fetal plasma concentration of IL-6 between fetuses with anemia and those without anemia. The median fetal plasma IL-6 concentration was higher in fetuses with anemia than that of those without anemia (3.74 pg/ml, interquartile range (IQR) 1.79–14.7 vs. 1.46 pg/ml, IQR 1.18–2.63; p = 0.02). The interrupted line represents the cutoff value of IL-6 concentration for the diagnosis of FIRS. All fetuses with FIRS had anemia (‘empty’ dots).

Figure 2.  Comparison of fetal plasma concentration of IL-6 between fetuses with anemia and those without anemia. The median fetal plasma IL-6 concentration was higher in fetuses with anemia than that of those without anemia (3.74 pg/ml, interquartile range (IQR) 1.79–14.7 vs. 1.46 pg/ml, IQR 1.18–2.63; p = 0.02). The interrupted line represents the cutoff value of IL-6 concentration for the diagnosis of FIRS. All fetuses with FIRS had anemia (‘empty’ dots).

Figure 3.  Comparison of amniotic fluid concentration of IL-6 between fetuses with anemia and those without anemia. The median amniotic fluid IL-6 concentration was not significantly different between women with anemic fetuses and those with fetuses without anemia (anemia: 1089 pg/ml, interquartile range (IQR) 542–2009 vs. no anemia: 471.5 pg/ml, IQR 357–693; p = 0.06). Intra-amniotic inflammation was diagnosed in only one fetus with FIRS. The interrupted line represents the cutoff value of amniotic fluid IL-6 concentration for the diagnosis of intra-amniotic inflammation. The ‘empty’ dots represent fetuses with FIRS.

Figure 3.  Comparison of amniotic fluid concentration of IL-6 between fetuses with anemia and those without anemia. The median amniotic fluid IL-6 concentration was not significantly different between women with anemic fetuses and those with fetuses without anemia (anemia: 1089 pg/ml, interquartile range (IQR) 542–2009 vs. no anemia: 471.5 pg/ml, IQR 357–693; p = 0.06). Intra-amniotic inflammation was diagnosed in only one fetus with FIRS. The interrupted line represents the cutoff value of amniotic fluid IL-6 concentration for the diagnosis of intra-amniotic inflammation. The ‘empty’ dots represent fetuses with FIRS.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.